Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Journal of Human Hypertension|February 1, 1993
Preclinical and clinical pharmacology of carvedilolR R Ruffolo, D A Boyle, R P Venuti, et al.Pharmacology|February 19, 1998
Evaluation of intrinsic sympathomimetic activity of bucindolol and carvedilol in rat heartR N Willette, M P Mitchell, E H Ohlstein, et al.The American Journal of Cardiology|October 30, 1998
Effectiveness of three different doses of carvedilol for exertional angina. Carvedilol-Angina Study GroupR Weiss, D Ferry, E Pickering, et al.Journal of Cardiac Failure|September 21, 2000
Rationale, design, and methods for a Coreg (carvedilol) Heart Failure Registry (COHERE). COHERE Participant PhysiciansJ A Franciosa, W T Abraham, M Fowler, et al.The New England Journal of Medicine|May 3, 2001
Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failureC W Yancy, M B Fowler, W S Colucci, et al.Journal of the American College of Cardiology|May 10, 2001
Influence of carvedilol on hospitalizations in heart failure: incidence, resource utilization and costs. U.S. Carvedilol Heart Failure Study GroupM B Fowler, M Vera-Llonch, G Oster, et al.Diabetic Medicine : a Journal of the British Diabetic Association|April 25, 2007
Differential effect of beta-blocker therapy on insulin resistance as a function of insulin sensitizer use: results from GEMINIV Fonseca, G L Bakris, D S H Bell, et al.Journal of Cardiac Failure|October 23, 1997
Safety and efficacy of carvedilol in severe heart failure. The U.S. Carvedilol Heart Failure Study GroupJ N Cohn, M B Fowler, M R Bristow, et al.Diabetes, Obesity & Metabolism|March 30, 2007
beta-blocker use and diabetes symptom score: results from the GEMINI studyJ B McGill, G L Bakris, V Fonseca, et al.Circulation|December 1, 1996
Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study GroupW S Colucci, M Packer, M R Bristow, et al.Pageof 3